The global stereotactic surgery devices market is poised for substantial growth, projected to increase from USD 26.34 billion in 2023 to an impressive USD 39.36 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.1% during the forecast period.
Key Drivers of Growth:
The growth of the stereotactic surgery devices market is being driven by several key factors, including the increasing demand for minimally invasive surgeries, advancements in surgical technologies, and a rise in cancer prevalence. Stereotactic surgery is gaining widespread acceptance due to its precision and ability to treat a variety of medical conditions, including cancer, arteriovenous malformations, epilepsy, and Parkinson’s disease.
In addition to its broadening applications, stereotactic radiosurgery has emerged as one of the most effective treatments for cancer, offering high-dose radiation with exceptional precision, minimizing the impact on healthy surrounding tissues. Technological improvements in equipment, such as the Varian Medical Systems’ Edge radiosurgery system, have enhanced treatment accuracy, further boosting the market’s growth.
Impact of the Pandemic:
The COVID-19 pandemic significantly disrupted the global healthcare sector, including the stereotactic surgery devices market. In the early months of the pandemic, countries like India and Malaysia saw a sharp decline in medical tourism due to travel restrictions. However, recovery efforts, including mass vaccinations and government support, helped restore market activities, paving the way for a swift rebound in the latter half of the pandemic.
Growing Applications in Medical Conditions:
The rising prevalence of cancer and other neurological conditions such as arteriovenous malformations and Parkinson’s disease is expected to drive the adoption of stereotactic surgery devices. As governments and healthcare organizations continue to invest in research and development, the market is poised for further advancements, particularly in the treatment of these critical conditions.
Technological Innovations in Stereotactic Radiosurgery:
Stereotactic radiosurgery, an integral part of stereotactic surgery, is benefiting from ongoing innovations. For instance, the introduction of next-generation equipment, such as Elekta AB’s Elekta Spirit and Elekta Harmony radiation therapy system, is revolutionizing the field with enhanced precision and treatment efficiency.
Surge in Market Needs: Discover Comprehensive Analysis and Insights in Our Detailed Report!
Challenges to Market Growth:
Despite these advancements, the high cost of stereotactic surgery instruments poses a challenge to market expansion, particularly in regions where healthcare funding is limited. The high costs associated with systems like Linear Accelerators (LINAC) and Gamma Knife may impede widespread adoption in some countries.
Regional Insights:
North America currently dominates the stereotactic surgery devices market, thanks to robust healthcare infrastructure, high awareness, and ongoing investments in medical research. The market is also experiencing significant growth in regions such as Europe and the Asia Pacific, where there is a growing demand for advanced treatment options.
Key Developments:
- October 2021: Ion Beam Applications SA launched the world’s first online proton therapy platform.
- June 2021: Navi Netics Inc. received premarket approval from the US FDA for its NaviNeticsD1 Stereotactic System.
- May 2022: Elekta AB introduced Elekta Spirit, a new Gamma Knife designed for sub-millimeter accuracy and rapid treatment planning.
Leading Companies in the Stereotactic Surgery Devices Market:
- Koninklijke Philips N.V.
- Hitachi Medical Systems
- Huiheng Group
- Siemens AG
- Elekta AB
- Varian Medical Systems
- IBA
- Accuray Incorporated
Market Segmentation: The stereotactic surgery devices market is segmented by product, application, and region:
- By Product: Gamma Knife, LINAC, PBRT, Cyber Knife
- By Application: Liver, Breast, Prostate, Lung, Colon
- By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
As the demand for advanced treatment methods continues to grow, the stereotactic surgery devices market is set to expand, with cutting-edge technology at the forefront of delivering more accurate and effective medical solutions.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube